Fund Tracker
AJANTPHARMNSEHealthcarePharmaceuticals & Biotechnology

Ajanta Pharma Limited

₹3,547.80NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 14 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
10.39%▼ −0.11 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
7.68%
as of 30 Jun 2026
Fund houses holding
9no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
22.53%
as of 30 Jun 2026

What changed

9 tracked fund houses held AJANTPHARM in Aug 2026. None entered or exited.

All tracked schemes together held 1.30 cr shares, 10.39% of equity, worth ₹4,675 cr at the end of Aug 2026.

Index and arbitrage funds held 0.27% of equity; they are left out of the fund-house counts.

MF houses

Aug 2026
9no change m/m
New0Added1Reduced4Exited0

Top buyer NJ Mutual Fund, +0.00% of equity. Top seller Bandhan Mutual Fund, −0.08% of equity. Index and arbitrage funds hidden.

AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure) 9 fund houses →

Named FPIs at 1% or more

as of 30 Jun 2026
7.68%

FPI category I + II, % of total shares · 0 named at 1% or more

No FPI held 1% or more of AJANTPHARM on 30 Jun 2026.

Shareholding pattern as of 30 Jun 2026, filed 14 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly

Insider and promoter

29 Jun 2026 to 26 Sep 2026
2▼ net −3,225 sh

disclosed transactions · equity bought 0 sh, sold 3,225 sh

Latest: A V JAYAKUMAR (Designated Person), Sell 2,500 Equity worth ₹81,77,500, 29 Jun 2026, Market Sale.

Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)

Bulk and block deals

25 Sep 2026
No bulk or block deals in AJANTPHARM on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily

Promoter pledge

as of 30 Jun 2026
22.53%

of promoter holding · 14.30% of total shares

Promoters had pledged 1.79 cr of their 7.93 cr shares on 30 Jun 2026; 1.79 cr encumbered in all (pledge, NDU and other).

Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly

SLBM borrowing

25 Sep 2026
NSE listed no SLBS open position for AJANTPHARM on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in AJANTPHARM on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily

MTF book

24 Sep 2026
43,719 sh▲ +269 vs 23 Sep 2026

percentile 7 of 29 days collected · ₹15.1 cr financed

43,719 shares, 0.03% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 7 of 29 days collected.

NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily

Delivery

25 Sep 2026
66.9%▲ +12.3 pp vs 20-day average

20-day average 54.6% · percentile 93 of 30 days collected

66.9% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 54.6%; that day sits at percentile 93 of 30 days collected.

NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily

Red flags

25 Sep 2026
No F&O

AJANTPHARM has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed AJANTPHARM under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.

NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily